ACAD - ACADIA Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ACAD is currently covered by 19 analysts with an average price target of $30.8. This is a potential upside of $6.78 (28.23%) from yesterday's end of day stock price of $24.02.

ACADIA Pharmaceuticals's activity chart (see below) currently has 504 price targets and 342 ratings on display. The stock rating distribution of ACAD is 22.22% HOLD, 75% BUY and 2.78% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 65.44% with an average time for these price targets to be met of 257.41 days.

Highest price target for ACAD is $39, Lowest price target is $17, average price target is $28.5.

Most recent stock forecast was given by AMI FADIA from NEEDHAM on 05-Nov-2025. First documented stock forecast 05-May-2013.

Currently out of the existing stock ratings of ACAD, 8 are a HOLD (22.22%), 27 are a BUY (75%), 1 are a SELL (2.78%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$29

$4.98 (20.73%)

$28

10 days ago
(05-Nov-2025)

0/11 (0%)

$7.35 (33.95%)

Buy

$32

$7.98 (33.22%)

$40

10 days ago
(05-Nov-2025)

0/3 (0%)

$10.35 (47.81%)

Buy

$33

$8.98 (37.39%)

$34

1 months 18 days ago
(28-Sep-2025)

8/13 (61.54%)

$11.68 (54.78%)

113

Buy

$39

$14.98 (62.36%)

$35

2 months 5 days ago
(10-Sep-2025)

7/12 (58.33%)

$14.8 (61.16%)

671

Buy

$39

$14.98 (62.36%)

$32

2 months 7 days ago
(08-Sep-2025)

1/5 (20%)

$14.16 (57.00%)

349

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ACAD (ACADIA Pharmaceuticals) average time for price targets to be met?

On average it took 257.41 days on average for the stock forecasts to be realized with a an average price target met ratio 65.44

Which analyst has the current highest performing score on ACAD (ACADIA Pharmaceuticals) with a proven track record?

CORY KASIMOV

Which analyst has the most public recommendations on ACAD (ACADIA Pharmaceuticals)?

Cory Kasimov works at EVERCORE and has 8 price targets and 6 ratings on ACAD

Which analyst is the currently most bullish on ACAD (ACADIA Pharmaceuticals)?

Alan Carr with highest potential upside - $35.98

Which analyst is the currently most reserved on ACAD (ACADIA Pharmaceuticals)?

Chris Howerton with lowest potential downside - -$9.02

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?